Press Releases

NEWS INFORMATION
July 14, 2004
Contact: Jim Johnson
Phone: (707) 547-2520
Email: sales@innovadyne.com

Innovadyne Added to GlaxoSmithKline (GSK) Preferred Supplier List

Santa Rosa, CA, July 14, 2004.

Innovadyne Technologies, Inc. today announced that GlaxoSmithKline has selected Innovadyne as a global preferred supplier for low-volume dispense technology. The announcement comes after a period of extensive evaluation and testing of Innovadyne’s Nanodrop™ platforms for HTS and UHTS assays at several GSK sites. Innovadyne’s platforms will now be placed in assay development and HTS groups at multiple sites in the US and Europe. The products will be used to minaturize a broad range of existing assays as well as helping to implement newer technologies such as those utilizing cells and beads.

“We are delighted GlaxoSmithKline has decided to implement our technology on a global basis and pleased to be included on this prestigious list,” said Joel McComb, Innovadyne’s President and CEO. “I view GlaxoSmithKline’s selection as a validation of both Innovadyne’s people and our company’s commitment to providing robust, best of class, low-volume liquid handling products.” Kevin Barrett, Innovadyne’s Managing Director, Europe, adds, “We have been extremely impressed with GlaxoSmithKline’s expertise in liquid handling and look forward to assisting them in their global assay miniaturization efforts.”

About Innovadyne

Innovadyne Technologies, Inc., headquartered in Santa Rosa, CA, is a rapidly growing, privately-held company that provides robust fluidics solutions to life science researchers in HTS, Genomics and Proteomics markets. The Company’s proprietary technology offers tools that enable increases in throughput, sensitivity and flexibility for assays, while significantly lowering reagent and other related costs. For additional information, please visit www.innovadyne.com.

About GlaxoSmithKline

GlaxoSmithKline, one of the world’s leading research-based pharmaceutical and healthcare companies, is committed to improving the quality of human life by enabling people to do more, feel better and live longer.